The ELEGANT Trial: Elevate Transvaginal Mesh vs. Anterior Colporrhaphy

NCT ID: NCT01497171

Last Updated: 2014-08-21

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE4

Total Enrollment

5 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-11-30

Study Completion Date

2013-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is designed to compare the safety and efficacy of a commercially available mesh kit used for surgical repair of anterior vaginal wall prolapse with traditional suture repair surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a multicenter, double blinded, randomized controlled trial, comparing Elevate® System with Interpro® Lite™, Anterior and Apical Prolapse Repair System (American Medical Systems) and Anterior Colporrhaphy (anterior suture repair) in women with symptomatic pelvic organ prolapse, who have opted to have surgical repair.

The goals of the study are to compare both efficacy and safety of the two procedures and to compare the surgical impact of mesh and suture repairs on vaginal function.

The principal investigator is from Mayo Clinic in Rochester, Minnesota. Mayo Clinic will serve as the data gathering and coordination site for this multicenter trial.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pelvic Organ Prolapse

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Elevate Mesh

Elevate transvaginal mesh - surgical repair of prolapse

Group Type ACTIVE_COMPARATOR

Elevate Mesh

Intervention Type PROCEDURE

Transvaginal mesh repair of anterior vaginal prolapse

Anterior Colporrhaphy

Anterior colporrhaphy - surgical repair of prolapse

Group Type ACTIVE_COMPARATOR

Anterior Colporrhaphy

Intervention Type PROCEDURE

Traditional suture repair of anterior vaginal prolapse

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Elevate Mesh

Transvaginal mesh repair of anterior vaginal prolapse

Intervention Type PROCEDURE

Anterior Colporrhaphy

Traditional suture repair of anterior vaginal prolapse

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women with symptomatic pelvic organ prolapse who opt for a vaginal repair
* Require both apical and anterior compartment repairs
* Willing to return for follow-up visit
* Understand and have signed informed consent to undergo randomization
* Need both an apical and anterior repair
* All trial participants who have a uterus will require a hysterectomy

Exclusion Criteria

* Known or suspected vulvodynia
* Known or suspected interstitial cystitis
* History of chronic pelvic pain
* Current pregnancy
* Desire to maintain fertility
* History of reconstructive pelvic surgery with synthetic mesh
* History of radical pelvic surgery
* History of pelvic radiation therapy
* Currently undergoing treatment for a malignancy
* Medically poor candidates for surgery
Minimum Eligible Age

21 Years

Maximum Eligible Age

80 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

American Medical Systems

INDUSTRY

Sponsor Role collaborator

Emanuel Trabuco

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emanuel Trabuco

Assistant Professor of Obstetrics-Gynegology, Consultant-OB/Gyn Surgery

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emanuel Trabuco, MD

Role: PRINCIPAL_INVESTIGATOR

Mayo Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kaiser-Permanente - North Valley

Roseville, California, United States

Site Status

Kaiser-Permanente - Santa Clara

Santa Clara, California, United States

Site Status

Stanford University School of Medicine

Stanford, California, United States

Site Status

Washington Hospital Center - MedStar Health

Washington D.C., District of Columbia, United States

Site Status

The Carl & Edyth Lindner Center for Research and Education at The Christ Hospital

Cincinnati, Ohio, United States

Site Status

St. Hedwig's Krankenhaus

Berlin, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

11-000247

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Avaulta Versus Anterior Repair
NCT00627549 UNKNOWN NA